Summary Basis of Decision for Redemplo
Health Canada granted a Notice of Compliance for Redemplo (ranolazine) for the management of chronic angina in adults. The approval is final and supported…
Impact analysis · 43/100 · AI-assisted priority
This score prioritizes research; it does not predict an outcome. Method and limitations.
What happened
Health Canada granted a Notice of Compliance for Redemplo (ranolazine) for the management of chronic angina in adults. The approval is final and supported by clinical data submitted in the regulatory dossier.
Quantitative evidence
- Approved indication: chronic angina
- Active substance: ranolazine
- Applicant: New Drug Submission
- Pivotal clinical study details
- n= and efficacy endpoints
- Sponsor/manufacturer name
Affected entities
Analysis
The following contextual analysis is AI-assisted and separated from the reported primary-source record above.
Scientific context
Ranolazine inhibits the late sodium current in cardiac cells and is approved as adjunctive therapy for chronic angina.
Market context
Redemplo enters a therapeutic area with generic competition and established treatment protocols.
Legal and regulatory context
A Notice of Compliance for Redemplo authorizes commercial sale for chronic angina in Canada.
Sources
For informational use only. Verify decisions against the linked regulator or primary source.
Evidence & limits
Source: Open the source record
- Record identifier
- 35e98aee4ad294403ec0cee61ed7f4011b6750cd121f76972b1cba40139a1a83
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- 2026-06-05T213025Z
What it supports. The linked authority’s action, within the product, indication, jurisdiction, and procedural stage stated in that record.
Limits. A committee opinion, draft, or announcement does not by itself establish final authorization. The summary and contextual analysis are AI-assisted; a source link does not establish human review.
Connection basis. Related profiles are normalized name mentions in article text. A mention does not establish a legal relationship.